Innoplexus

The AI engine Fit Assessment

Beta

INNOPLEXUS effectively leverages machine learning to discover patterns and expand therapeutics, while also focusing on biomarker identification for personalized medicine.

Blurb

Innoplexus™ - AI and Blockchain powered data analytics solutions help the life science industry gain real-time access to relevant insights

HQ Location

Eschborn (Germany)

Founded

2011

Employees

201 - 500

Total funding raised

Not available

Funding Status

Series C, April 24, 2019
Subspaces
  • Biomarker Identification

Developer of advanced artificial intelligence and blockchain technology platform designed to support all stages of drug development from pipeline to market. The company's platform identifies and extracts structured and unstructured life science data by scanning the World Wide Web and merges it with enterprise and third-party data in an ongoing, real-time process, enabling life sciences organizations to generate actionable insights across pre-clinical, clinical, regulatory, and commercial stages of drug development using data analytics.